FDA Approves First-Ever Twice-Yearly HIV Prevention Injection: A New Era in Global Health
In a groundbreaking step forward in the fight against HIV, the U.S. Food and Drug Administration (FDA) has approved Yeztugo (lenacapavir) — the first and only twice-yearly injection for HIV prevention. This historic decision, announced on June 18, 2025, marks a major milestone in medical innovation and public health strategy. 🧬 What Is Yeztugo (Lenacapavir)? […]